A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects

NCT04904913 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight/ Obesity

Interventions

DRUG: IBI362
OTHER: placebo

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.